Literature DB >> 21509680

Molecular pathogenesis of multiple myeloma: chromosomal aberrations, changes in gene expression, cytokine networks, and the bone marrow microenvironment.

Bernard Klein, Anja Seckinger, Thomas Moehler, Dirk Hose.   

Abstract

This chapter focuses on two aspects of myeloma pathogenesis: (1) chromosomal aberrations and resulting changes in gene and protein expression with a special focus on growth and survival factors of malignant (and normal) plasma cells and (2) the remodeling of the bone marrow microenvironment induced by accumulating myeloma cells. We begin this chapter with a discussion of normal plasma cell generation, their survival, and a novel class of inhibitory factors. This is crucial for the understanding of multiple myeloma, as several abilities attributed to malignant plasma cells are already present in their normal counterpart, especially the production of survival factors and interaction with the bone marrow microenvironment (niche). The chapter closes with a new model of pathogenesis of myeloma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21509680     DOI: 10.1007/978-3-540-85772-3_3

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  10 in total

Review 1.  Targeting the interplay between myeloma cells and the bone marrow microenvironment in myeloma.

Authors:  Masahiro Abe
Journal:  Int J Hematol       Date:  2011-10-18       Impact factor: 2.490

2.  The relationship between soluble receptor of interleukin-6 with angiogenic cytokines and proliferation markers in multiple myeloma.

Authors:  George Tsirakis; Constantina A Pappa; Maria Kaparou; Anna Boula; Vaitsa Katsomitrou; Athina Xekalou; Stavroula Kyriakaki; Michael G Alexandrakis
Journal:  Tumour Biol       Date:  2012-12-16

3.  Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth.

Authors:  Emanuela Leone; Eugenio Morelli; Maria T Di Martino; Nicola Amodio; Umberto Foresta; Annamaria Gullà; Marco Rossi; Antonino Neri; Antonio Giordano; Nikhil C Munshi; Kenneth C Anderson; Pierosandro Tagliaferri; Pierfrancesco Tassone
Journal:  Clin Cancer Res       Date:  2013-02-27       Impact factor: 12.531

4.  Circulating levels of soluble Fas ligand reflect disease progression in multiple myeloma.

Authors:  Michael G Alexandrakis; Constantina A Pappa; Anna Kolovou; Stavroula Kyriakaki; Rodanthi Vyzoukaki; Maria Devetzoglou; George Tsirakis
Journal:  Med Oncol       Date:  2014-04-13       Impact factor: 3.064

5.  TPL2 kinase regulates the inflammatory milieu of the myeloma niche.

Authors:  Chelsea Hope; Samuel J Ollar; Erika Heninger; Ellen Hebron; Jeffrey L Jensen; Jaehyup Kim; Ioanna Maroulakou; Shigeki Miyamoto; Catherine Leith; David T Yang; Natalie Callander; Peiman Hematti; Marta Chesi; P Leif Bergsagel; Fotis Asimakopoulos
Journal:  Blood       Date:  2014-04-10       Impact factor: 22.113

6.  [Interaction between myeloma cells and bone tissue].

Authors:  A Seckinger; D Hose
Journal:  Radiologe       Date:  2014-06       Impact factor: 0.635

7.  Differential effects of lenalidomide during plasma cell differentiation.

Authors:  Michel Jourdan; Maïlys Cren; Peter Schafer; Nicolas Robert; Christophe Duperray; Laure Vincent; Patrice Ceballos; Guillaume Cartron; Jean-François Rossi; Jérôme Moreaux; Rajesh Chopra; Bernard Klein
Journal:  Oncotarget       Date:  2016-05-10

8.  Diagnostic and therapeutic approaches to multiple myeloma patients: 'Real-world' data from representative multicentre treatment surveys in Germany between 2008 and 2011.

Authors:  Thomas M Moehler; Maximilian Merz; Lenka Kellermann; Hartmut Goldschmidt; Wolfgang Knauf
Journal:  Oncol Lett       Date:  2016-11-10       Impact factor: 2.967

9.  Residual malignant and normal plasma cells shortly after high dose melphalan and stem cell transplantation. Highlight of a putative therapeutic window in Multiple Myeloma?

Authors:  Anouk Caraux; Laure Vincent; Salahedine Bouhya; Philippe Quittet; Jérôme Moreaux; Guilhem Requirand; Jean-Luc Veyrune; Gaëlle Olivier; Guillaume Cartron; Jean-François Rossi; Bernard Klein
Journal:  Oncotarget       Date:  2012-11

10.  Quantification of plasma cell dynamics using mathematical modelling.

Authors:  Marcel Mohr; Dirk Hose; Anja Seckinger; Anna Marciniak-Czochra
Journal:  R Soc Open Sci       Date:  2018-01-24       Impact factor: 2.963

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.